Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

NCT05427812 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: ISB 1442 SC injection escalating doses
DRUG: ISB 1442 SC injection at RP2D

Sponsor

Ichnos Sciences SA